Aegros Appoints Father of India’s Blood Plasma Industry as Chief Executive Officer of Aegros Asia
The Aegros Group is pleased to announce that it has appointed Dr. Ranjeet S. Ajmani to the role of Chief Executive Officer of Aegros Asia. Dr Ajmani is called the father of India’s blood plasma industry and has a well-established and respected reputation across South-East Asia for his academic, commercial, and policy work setting up […]
Aegros to present findings at ISTH 2023 Pt 2 – Hyperimmune neutralisation against Covid-19 variants
The International Society on Thrombosis and Homeostasis (ISTH) annual Congress is currently underway in Montreal, June 24 – 28, and Aegros is there to present two research papers to the assembled practitioners and experts. Recently Aegros shared with you the findings of its first paper into Plasma Fractionation by HaemaFrac® Technology – A Bioprocessing Innovation, […]
Aegros to present findings at ISTH 2023 Pt 1
The International Society on Thrombosis and Homeostasis (ISTH) is holding its annual Congress in Montreal, June 24 – 28, and Aegros will be there to present two research papers to the assembled practitioners and experts. In this update, we’ll look at one of those research papers titled Plasma Fractionation by HaemaFrac® Technology – A Bioprocessing […]
Signing in Blood (Plasma)
Aegros has secured its supply of 100,000L of convalescent plasma for the next three years.
Aegros at ARCS
ARCS is a professional body that focuses on the careers and professional development of those working in the therapeutic goods sector, and Aegros is pleased to be involved with and attend its annual conference, held June 6-8 at the International Convention Centre, Darling Harbour. Aegros’ involvement comes by way of Shanthi Vijayakumar, Head of Regulatory […]
Aegros June Update
Aegros is pleased to share this update on our operations, planning and strategies with investors. This update was filmed in conjunction with STK Markets and includes the latest information on Aegros’ activities, delivered by Founders, Professor Hari Nair and John Manusu. Information in this update includes: 1. Clinical Trials update 2. F(actory) A(cceptance) T(est) in […]
Primary Immunity Week was a Chance to Learn
Aegros’ Chief Medical Officer Dr Leon Rozen used the opportunity of Primary Immunity Week to shed a little light for his colleagues, by way of a fireside chat, on the various primary immunity diseases that Aegros will make medicines for. In this 20-minute discussion Dr Rozen informed us about some of the more prevalent types […]
HF-02: The next evolution of HaemaFrac®
Damian Thornton, CEO of Aegros Engineering and Interim CEO of Aegros Therapeutics, is at the Telstar manufacturing facility in Barcelona Spain, and is pleased to present a short look at Aegros’ new HF-02 HaemaFrac® as it begins its factory acceptance test regime. This new machine is the next stage in the evolution not only of […]
Aegros Agreement Ensures BioPark Australia
Left to right: Aegros Co-founders Mr John Manusu and Professor Hari Nair, along with Mr Maha Sinnathamby AM and Mr Bob Sharpless from the Springfield City Group, sign the heads of agreement to build Aegros’ new one million litre facility at BioPark Australia. On Thursday 20 April Aegros Founders, Professor Hari Nair and Mr John […]
Aegros R&D Open Day – Video Available
We are very pleased to be able to share with you the video of the speeches and presentations delivered to guests and attendees of the Aegros R&D Open Day, held at Macquarie Park NSW on 14 March (see below for a PDF of the presentations). Over 50 people attended the Aegros R&D Open Day including […]
